Search:

Partnership opportunities

Our technology in action

Patient information

Contact us

Clinical trials status

Click on the title to get more information.

Recruiting	Phase I single site study using Heat Activated Liposomal Doxorubicin and Hyperthermia to treat patients with loco-regional recurrent breast cancer Conditions: Loco-regional breast carcinoma of the chest wall and /or its overlying skin, with or without metastases
Recruiting	Phase III Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC) Condition: Hepatocellular Carcinoma Interventions: Drug: ThermoDox; Drug: 5% Dextrose Solution
Recruiting	A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver Conditions: Hepatocellular Carcinoma; Liver Neoplasms Intervention: Drug: ThermoDox
No Longer Recruiting	Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors Conditions: Liver Cancer; Metastatic Cancer Interventions: Drug: lyso-thermosensitive liposome doxorubicin; Procedure: chemotherapy; Procedure: radiofrequency ablation

For further information on all clinical trials please refer to www.clinicaltrials.gov.